Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta] (2012)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-011-2495-x
- Subjects: CANNABIS (COMPONENTES;EFEITOS); INTERAÇÃO DE DROGAS; FARMACODINÂMICA
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2012
- Source:
- Título do periódico: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 219, n. 1, p. 247-249, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ZUARDI, Antonio Waldo e HALLAK, Jaime Eduardo Cecílio e CRIPPA, José Alexandre de Souza. Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta]. Psychopharmacology. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00213-011-2495-x. Acesso em: 19 abr. 2024. , 2012 -
APA
Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. de S. (2012). Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta]. Psychopharmacology. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s00213-011-2495-x -
NLM
Zuardi AW, Hallak JEC, Crippa JA de S. Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta] [Internet]. Psychopharmacology. 2012 ; 219( 1): 247-249.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00213-011-2495-x -
Vancouver
Zuardi AW, Hallak JEC, Crippa JA de S. Interaction between cannabidiol (CBD) and 'delta 9'-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids [Carta] [Internet]. Psychopharmacology. 2012 ; 219( 1): 247-249.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00213-011-2495-x - Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
Informações sobre o DOI: 10.1007/s00213-011-2495-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
